Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
He<strong>al</strong>th Technology Assessment 1997; Vol. 1: No. 4BibliographyThere are more than 500 papers on fragile X syndrome which we have consulted in d<strong>et</strong>ailwhile carrying out this systematic review. Not <strong>al</strong>l of them are referred to directly in the report butthey <strong>al</strong>l are listed here in <strong>al</strong>phab<strong>et</strong>ic<strong>al</strong> order. Other papers are referenced (e.g. on the risks ofamniocentesis) that do not relate to fragile X syndrome and these <strong>for</strong>m a separate <strong>al</strong>phab<strong>et</strong>ic<strong>al</strong>list at the end of this bibliography.Abrams MT, Reiss AL, 1995. Quantitative brainimaging studies of fragile-X syndrome. Dev BrainDysfunction;8(4–6):187–98.Abrams MT, Reiss AL, Freund LS, BaumgardnerTL, Chase GA, Denckla MB, 1994. Molecularneurobehavior<strong>al</strong>associations in fem<strong>al</strong>es with thefragile X full mutation. Am J Med Gen<strong>et</strong>ics;51:317–27.Abruzzo MA, Mayer M, Jacobs PA, 1985. The effect ofm<strong>et</strong>hionine and 5-azacytidine on fragile X expression.Am J Human Gen<strong>et</strong>ics;37:193–8.Abruzzo MA, Hunt PA, Mayer M, Jacobs PA, Wang JC,Erbe R, 1986. A comparison of fragile X expression inlymphocyte and lymphoblastoid cultures. Am J HumanGen<strong>et</strong>ics;38:533–9.American College of Medic<strong>al</strong> Gen<strong>et</strong>ics, 1994. <strong>Fragile</strong>X syndrome: diagnostic and carrier testing. Am J MedGen<strong>et</strong>ics;53:380–1.Arinami T, Kondo I, Nakajima S, 1986. Frequency of thefragile X syndrome in Japanese ment<strong>al</strong>ly r<strong>et</strong>arded m<strong>al</strong>es.Human Gen<strong>et</strong>ics;73:309–12.Arinami T, Asano M, Kobayashi K, Yanagi H, HamaguchiH, 1993. Data on the CGG repeat at the fragile X sitein the non-r<strong>et</strong>arded Japanese population and familysuggest the presence of a subgroup of norm<strong>al</strong> <strong>al</strong>lelespredisposing to mutate. Human Gen<strong>et</strong>ics;92:431–6.Ashley AE, Sherman SL, 1995. Population dynamicsof a meiotic/mitotic expansion model <strong>for</strong> the fragileX syndrome. Am J Human Gen<strong>et</strong>ics;57:1414–25.Ashley CT Jr, Wilkinson KD, Reines D, Warren ST, 1993a.FMR1 protein: conserved RNP family domains andselective binding. Science;262:563–6.Ashley CT, Sutcliffe JS, Kunst CB, <strong>et</strong> <strong>al</strong>, 1993b. Humanand murine FMR-1: <strong>al</strong>ternative splicing and translation<strong>al</strong>initiation downstream of the CGG-repeat. NatureGen<strong>et</strong>ics;4:244–51.Asthana JC, Sinha S, Haslam JS, Kingston HM, 1990.Survey of adolescents with severe intellectu<strong>al</strong> handicap.Arch Dis Childhood;65:1133–6.Azofeifa J, W<strong>al</strong>dherr R, Cremer M, 1996. X-chromosomem<strong>et</strong>hylation ratios as indicators of chromosom<strong>al</strong> activity:evidence of intraindividu<strong>al</strong> divergencies among tissuesof different embryon<strong>al</strong> origin. Human Gen<strong>et</strong>ics;97:330–3.Bachner D, Manca A, Steinbach P, <strong>et</strong> <strong>al</strong>, 1993. Enhancedexpression of the murine FMR1 gene during germ cellproliferation suggests a speci<strong>al</strong> function in both the m<strong>al</strong>eand the fem<strong>al</strong>e gonad. Human Molec Gen<strong>et</strong>ics;2:2043–50.Bakker C, Degraaff E, Zhong N, Willemsen R, OostraB, 1995. Instability of the CGG repeat and expressionof FMR1 protein in a m<strong>al</strong>e-patient with a lung-tumor.Am J Human Gen<strong>et</strong>ics;57:1359.Barnicoat A, Docherty Z, Bobrow M, 1993. Wherehave <strong>al</strong>l the fragile X boys gone? Dev Med ChildNeurology;35:532–9.Baumgardner TL, Reiss AL, Freund LS, Abrams MT,1995. Specification of the neurobehavior<strong>al</strong> phenotypein m<strong>al</strong>es with fragile X syndrome. Pediatrics;95:744–52.Bell MV, Hirst MC, Nakahori Y, <strong>et</strong> <strong>al</strong>, 1991. Physic<strong>al</strong>mapping across the fragile X: hyperm<strong>et</strong>hylationand clinic<strong>al</strong> expression of the fragile X syndrome.Cell;64:861–6.Berry-Kravis E, Sklena P, 1993. Demonstrationof abnorm<strong>al</strong> cyclic AMP production in platel<strong>et</strong>sfrom patients with fragile X syndrome. Am J MedGen<strong>et</strong>ics;45:81–7.Berry-Kravis E, Hicar M, Ciurlionis R, 1995.Reduced cyclic-amp production in fragile-Xsyndrome – cytogen<strong>et</strong>ic and molecular correlations.Ped Res;38:638–43.Billings P, Hubbard R, 1994. <strong>Fragile</strong> X testing: whobenefits? Genewatch;9:1–3.Black SH, 1994. Preimplantation gen<strong>et</strong>ic diagnosis[review]. Curr Opin Pediatrics;6:712–6.Blomquist HK, Gustavsion K, Holmgren G, NordensonI, Sweins A, 1982. <strong>Fragile</strong> site X chromosomes andX-linked ment<strong>al</strong> r<strong>et</strong>ardation in severely r<strong>et</strong>arded boysin a northern Swedish county. A prev<strong>al</strong>ence study.Clin Gen<strong>et</strong>ics;21:209–14.Blomquist HK, Gustavson KH, Holmgren G, NordensonI, P<strong>al</strong>sson-Strae U, 1983. <strong>Fragile</strong> X syndrome in mildlyment<strong>al</strong>ly r<strong>et</strong>arded children in a northern Swedish county.A prev<strong>al</strong>ence study. Clin Gen<strong>et</strong>ics;24:393–8.Bodurtha J, Tams L, Jackson-Cook C, 1992. Prenat<strong>al</strong>gen<strong>et</strong>ic counseling: what is fragile X [review]? VirginiaMed Quart;119(2):97–8.53